Hepatitis C virus vaccine design: focus on the humoral immune response

Hepatitis C virus vaccine design: focus on the humoral immune response

Abstract Despite the recent development of safe and highly effective direct-acting antivirals, hepatitis C virus (HCV) infection remains a significant health problem. In 2016, the World Health Organization set out to reduce the rate of new HCV infections by 90% by 2030. Still, global control of the...

Full description

Bibliographic Details
Main Authors: Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Journal of Biomedical Science
Subjects:
HCV
Antibody
Vaccine
Humoral immune response
Glycoprotein E1
Glycoprotein E2
Online Access:http://link.springer.com/article/10.1186/s12929-020-00669-4

Internet

http://link.springer.com/article/10.1186/s12929-020-00669-4

Similar Items